Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Ginkgo Bioworks Holdings, Inc. DNA

Set alert

Price alert · DNA

All alert types
9.85 USD -1.36 -12.13%

At close

10.00 +0.15 +1.52%

Pre-market · Nov 3, 8:39 AM ET

Bid
9.84 × 400
Ask
9.93 × 300
9.28 Day range 11.25
5.37 52-week range 18.22
YTD
+18.53%
1 year
-22.99%
Open
11.35
Prev close
11.21
Mkt cap
663.30M
Vol
3.55M
Avg vol
2.26M
EPS
-5.06
P/E
0.00
Div yield
0.00%
More statistics
Low
9.28
High
11.25
Forward P/E
-5.17
Beta
1.79
Short ratio
6.35
Inst. own
73.73%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
8.08
200-d avg
8.32
1y target
7.00

5D chart

Chart tools
Interval
1m5m15m30m

Signals (109)
NameTimeAgo
SMA: BearishNov 2, 2:35 PM18 hours ago
SMA: BullishNov 2, 2:10 PM18 hours ago
MACD: Buy SignalNov 2, 2:10 PM18 hours ago
RSI: OversoldNov 2, 1:50 PM18 hours ago
MACD: Sell SignalNov 2, 1:35 PM19 hours ago
SMA: BearishNov 2, 12:40 PM20 hours ago
SMA: BullishNov 2, 12:00 PM20 hours ago
SMA: BearishNov 2, 11:40 AM21 hours ago
RSI: OversoldNov 2, 11:40 AM21 hours ago
SMA: BullishNov 2, 11:30 AM21 hours ago
MACD: Buy SignalNov 2, 11:30 AM21 hours ago
RSI: OversoldNov 2, 10:40 AM22 hours ago
RSI: OversoldNov 2, 9:40 AM23 hours ago
MACD: Sell SignalNov 2, 9:35 AM23 hours ago
SMA: BearishNov 2, 9:30 AM23 hours ago
SMA: BearishNov 2, 9:30 AM23 hours ago
RSI: OverboughtOct 30, 3:35 PM3 days ago
SMA: BullishOct 30, 3:20 PM3 days ago
SMA: BullishOct 30, 3:10 PM3 days ago
MACD: Buy SignalOct 30, 3:10 PM3 days ago

Newest 20 of 109.

Analyst view

Consensus: none

Price target (mean) 7.00 -28.9% downside
Target (low)
5.00
Target (mean)
7.00
Target (high)
9.00
Ratings (0m) 3 0 buy · 1 hold · 2 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell1
  • Strong sell1

Recommendation trend

  • This month 3
  • 1 month ago 3

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DNA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.58-0.58 – -0.580.000.0%21.58M-44.4%1
Next quarter-0.82-0.82 – -0.82-1.42+42.3%23.85M-28.6%1
Current year-3.20-3.20 – -3.20-3.66+12.5%85.03M-50.0%1
Next year-2.90-2.90 – -2.90-3.20+9.4%96.40M+13.4%1

Upgrades and downgrades

The latest rating changes

DNA analyst upgrades and downgrades
DateFirmActionFromTo
Sep 4, 2026BTIGReiteratedSellSell
Aug 7, 2026TD CowenDowngradeBuyHold
Mar 12, 2026BTIGMaintainedSellSell
Jan 8, 2026TD CowenMaintainedBuyBuy
Aug 25, 2025BTIGMaintainedSellSell
Sep 20, 2024TD CowenMaintainedBuyBuy
Aug 23, 2024BTIGMaintainedSellSell
Jul 9, 2024Goldman SachsMaintainedSellSell
Jun 26, 2024BTIGMaintainedSellSell
May 15, 2024BTIGDowngradeNeutralSell
May 15, 2024Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 10, 2024William BlairDowngradeMarket PerformUnderperform
Mar 1, 2024TD CowenMaintainedOutperformOutperform
Jan 23, 2024Goldman SachsMaintainedSellSell
Jan 22, 2024Goldman SachsMaintainedSellSell
Nov 15, 2023Raymond JamesDowngradeOutperformMarket Perform
Nov 14, 2023Raymond JamesDowngradeOutperformMarket Perform
Nov 9, 2023BTIGDowngradeBuyNeutral
Jun 5, 2023Goldman SachsMaintainedSellSell
Jun 2, 2023Goldman SachsDowngradeNeutralSell
May 11, 2023William BlairDowngradeOutperformMarket Perform
Nov 29, 2022BerenbergInitiated—Buy
Oct 4, 2022Morgan StanleyInitiated—Equal-Weight
Aug 16, 2022BTIGMaintained—Buy
Aug 16, 2022Raymond JamesMaintained—Outperform
Jun 16, 2022JefferiesMaintained—Buy
May 18, 2022B of A SecuritiesDowngradeNeutralUnderperform
Mar 2, 2022Cowen & Co.Initiated—Outperform
Feb 23, 2022Goldman SachsInitiated—Neutral
Feb 1, 2022B of A SecuritiesInitiated—Neutral